Financials

  • Market Capitalization 518.8939 M
  • Employee 44
  • Founded 2024
  • CEO N/A
  • Website www.crescentbiopharma.com
  • Headquarter Cayman Islands
  • FIGI N/A
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.12
Price to sales ratio
1.75